A Single-center, Self-controlled, Prospective Case Series Pilot Study to Assess the Effect of Lamivudine (3TC) on Neurocognitive Impairment Biomarkers and Type-I IFN (Interferon)-Stimulated Genes in the Plasma of Patients With Mild Cognitive Impairment (MCI)
Clinical trial NCT06519357 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06519357
- Sponsor
- Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-28
- Primary completion
- 2025-09-05
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.